1. Hjermstad BM, Sobin LH, Helwig EB. Stromal tumors of the gastrointestinal tract. Myogenic or neurogenic?Am J Surg Pathol11:383-386, 1987
2.
2. Knapp RH, Wick MR, Goellner JR. Leiomyoblastomas and their relationship to other smoothmuscle tumors of the gastrointestinal tract. An electron-microscopic study. Am J Surg Pathol8:449-461, 1984
3.
3. Ma CK, Amin MB, Kintanar E, Linden MD, Zarbo RJ. Immunohistologic characterization of gastrointestinal stromal tumors: A study of 82 cases compared with 11 cases of leiomyomas. Mod Pathol6:139-144, 1993
5. Miettinen M.Gastrointestinal stromal tumors. An immunohistochemical study of cellular differentiation. Am J Clin Pathol89:601-610, 1988
6.
6. Saul SH, Rast ML, Brooks JJ. The immunohistochemistry of gastrointestinal stromal tumors. Evidence supporting an origin from smooth muscle. Am J Surg Pathol11:464-473, 1987
7.
7. Ureyama T, Guo KJ, Hashimoto H, Daimaru Y, Enjoji M.A clinicopathologic and immunohistochemical study of gastrointestinal stromal tumors. Cancer69:947-955, 1992
8.
8. Weiss RA, Mackay B.Malignant smooth muscle tumors of the gastrointestinal tract. An ultrastructural study of 20 cases. Ultrastruct Pathol2:231-240, 1981
10. Erlandson RA, Klimstra DS, Woodruff JM. Subclassification of gastrointestinal stromal tumor based on evaluation by electron microscopy and immunohistochemistry. Ultrastruct Pathol20:373-394, 1996
11.
11. Sakurai S, Fukasawa T, Chong JM, Tanaka A, Fukayama M.Embryonic form of smooth muscle myosin heavy chain (Smemb/MHC-B) in gastrointestinal stromal tumor and intestitial cell of Cajal. Am J Pathol154:23-28, 1999
12.
12. Miettinen MM, Sarlomo-Rikala M, Kovatich AJ, Lasota J.Calponin and h-Caldesmon in soft tissue tumors: Consistent h-Caldesmon immunoreactivity in gastrointestinal stromal tumors indicates traits of smooth muscle differentiation. Mod Pathol12:756-762, 1999
14. Lauwers GY, Erlandson RA, Casper ES, Brennan MF, Wodruff JM. Gastrointestinal autonomic nerve tumors. A clinicopathological, immunohistochemical, and ultrastructural study of 12 cases. Am J Surg Pathol17:887-897, 1993
15.
15. Perez-Atayde AR, Shamberger RC, Kozakevich HW. Neuroectodermal differentiation of the gastrointestinal tumor in the Carney triad. An ultrastructural and immunohistochemical study. Am J Surg Pathol17:706-714, 1993
17. Donner LR. Gastrointestinal autonomic nerve tumor: A common type of gastrointestinal stromal neoplasm. Ultrastruct Pathol21:419-424, 1997
18.
18. Shanks JH, Harris M, Banerjee SS, Eyden BP. Gastrointestinal autonomic nerve tumours: A report of nine cases. Histopathology29:112-121, 1996
19.
19. Hurlimann J, Gardiol D.Gastrointestinal stromal tumours. An immunohistochemical study of 165 cases. Histopathology19:311-320, 1991
20.
20. Mazur MT, Clark HB. Gastric stromal tumors. Reappraisal of histogenesis. Am J Surg Pathol7:507-519, 1983
21.
21. Daimuru Y, Kido H, Hashimoto H, Enjoji M.Benign schwannoma of the gastrointestinal tract. A clinicopathologic and immunohistochemical study. Hum Pathol19:257-264, 1988
22.
22. Prevot S, Bienvenu L, Vaillant JC, de Sain-Maur PP. Benign schwannoma of the digestive tract: A clinicopathologic and immunohistochemical study of five cases, including a case of esophageal tumor. Am J Surg Pathol23:431-436, 1999
23.
23. Rudolph P, Chiaravalli AM, Pauser U, Oschlies I, Hillemanns M, Gobbo M, Marichal M, Eusebi V, Hofler H, Capella C, Klopper G.Gastrointestinal mesenchymal tumors-immunophenotypic classification and survival analysis. Virchows Arch441:238-248, 2002
24.
24. Miettinen M, Virolainen M, Sarlomo-Rikala M.Gastrointestinal stromal tumors. Value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas. Am J Surg Pathol19:207-216, 1995
25.
25. Mikhael Al, Bacchi CE, Zarbo RJ, Ma CK, Gown AM. CD34 expression in stromal tumors of the gastrointestinal tract. Appl Immunohistochem2:84-93, 1994
26.
26. Moniham JM, Carr NJ, Sobin LH. CD34 immunoexpression in stromal tumours of the gastrointestinal tract and in mesenteric fibromatoses. Histopathology25:469-473, 1994
27.
27. Meissner WA. Leiomyosarcoma of the stomach. Arch Pathol38:207-209, 1944
28.
28. Mikami T, Terada T, Nakamura K, Okayasu I.The gastric hypercellular microleiomyoma as a precursor lesion for clinical gastrointestinal stromal tumors. Hum Pathol28:1355-1360, 1997
29.
29. Cornog JL Jr.Gastric leiomyoblastoma. A clinical and ultrastructural study. Cancer34:711-719, 1974
30.
30. Pizzimbono CA, Higa E, Wise L.Leiomyoblastoma of the lesser sac. Case report and review of the literature. Am Surg39:692-699, 1973
31.
31. Stout AP. Bizarre smooth muscle tumors of the stomach. Cancer15:400-409, 1962
32.
32. Tallquist G, Salmela H, Lindstrom BL. Leiomyoblastoma of the stomach. A clinicopathological study of 10 cases. Acta Pathol Microbiol Scand17:194-202, 1967
33.
33. Salazar H, Totten RS. Leiomyoblastoma of the stomach. An ultrastructural study. Cancer25:176-185, 1970
34.
34. Ritter JH, Mills SE, Gaffey MJ, Nappi O, Wick MR. Clear cell tumors of the alimentary tract and abdominal cavity. Semin Diagn Pathol14:213-219, 1997
35.
35. Tsutsumi Y, Jtazawa K, Shibuya M.Type VI collagen immunoreactivity in skeinoid fibers in small intestinal stromal tumors. Pathol Int49:836-839, 1999
36.
36. Mentzel T, Katenkamp D.Gastrointestinal stromal tumour with skeinoid fibres and bidirectional immunohistochemical differentiation. Histopathology29:175-177, 1996
37.
37. Matsukuma S, Doi M, Sukumi M, Ikegawa K, Sato K, Kuwabara N.Numerous eosinophilic globules (skenoid fibers) in a duodenal stromal tumor: An exceptional case showing smooth muscle differentation. Pathol Int47:789-793, 1997
38.
38. Hemmi A, Komiyama A, Ohno S, Fujii Y, Terada N, Katoh R, Yokoyama A, Kawaoi A.Autonomic nerve tumour with skeinoid fibres: Ultrastructure of skeinoid fibres examined by quick-freezing and deep-etching method. Virchows Arch434:267-276, 1999
39.
39. Suster S, Sorace D, Moran CA. Gastrointestinal stromal tumors with prominent myxoid matrix. Clinicopathologic, immunohistochemical, and ultrastructural study of nine cases of a distinctive morphologic variant of myogenic stromal tumor. Am J Surg Pathol19:59-70, 1995
40.
40. Suster S, Fletcher CDM. Gastrointestinal stromal tumors with prominent signet-ring cell features. Mod Pathol9:609-613, 1996
41.
41. Ferrer MD, Lloreta J, Corominas JM, Ribalta T, Iglesias M, Serrano S.Signet ring epithelioid stromal tumor of the small intestine. Ultrastruct Pathol23:45-50, 1999
42.
42. Yato T, Aoyagi K, Hizawa K, Kimura Y, Tsuneyoshi M.Gastric epithelioid stromal tumor (leiomyoma) with granular changes. Int J Surg Pathol4:37-42, 1996
44. Yagihashi N, Kaimori M, Katayama Y, Yagihashi S.Crystalloid formation in gastrointestinal schwannoma. Hum Pathol28:304-308, 1997
45.
45. Shek TW, Luk IS, Loong F, Ip P, Ma L.Inflammatory cell-rich gastrointestinal autonomic nerve tumor: An expansion of its histologic spectrum. Am J Surg Pathol20:325-331, 1996
46.
46. Leung KM, Wong S, Chow TC, Lee KC. A malignant gastrointestinal stromal tumor with osteoclastlike giant cells. Arch Pathol Lab Med16:972-974, 2002
47.
47. Tazawa K, Tsukada K, Makuuchi H, Tsusumi Y.An immunohistochemical and clinicopathologic study of gastrointestinal stromal tumors. Pathol Int49:786-798, 2001
48.
48. Chambonniere ML, Mosnier-Damet M, Mosnier JF. Expression of microtubule-associated protein tau by gastrointestinal stromal tumors. Hum Pathol32:1166-1173, 2001
49.
49. Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kamano K, Hanada M, Kurata A, Takeda M, Muhammad, Tunio GM, Matsuzawa Y, Kanakura Y, Shinomura Y, Kitamura Y.Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science279:577-580, 1998
50.
50. Heinrich MC, Rubin BP, Longley B, Fletcher JA. Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations. Hum Pathol33:484-495, 2002
51.
51. Corless Cl, McGreevey L, Haley A, Town A, Heirich MC. KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter of less in size. Am J Pathol160:1567-1572, 2002
52.
52. Warldelmann E, Neidt I, Bierhoff E, Speidel N, Manegold C, Fischer H-P, Pfeifer U, Pietsch T.C-kit mutations in gastrointestinal stromal tumors occur preferentially in the spindle rather than in the epithelioid cell variant. Mod Pathol15:125-136, 2002
53.
53. Andersson J, Sjogren H, Meis-Kindblom JM, Stenman G, Aman P, Kindblom LG. The complexity of KIT gene mutations and chromosome rearrangements and their clinical correlation in gastrointestinal stromal (pacemaker cell) tumors. Am J Pathol160:15-22, 2002
55. Rubin BP, Fletcher JA, Fletcher CDM. Molecular insights into the histogenesis and pathogenesis of gastrointestinal stromal tumors. Int J Surg Pathol8:5-11, 2000
56.
56. Hornick JL, Fletcher CDM. Immunohistochemical staining for KIT (CD1 17) in soft tissue sarcomas is very limited in distribution. Am J Clin Pathol117:188-193, 2002
57.
57. Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, Miettinen M. CD1 17: A sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol11:728-734, 1998
58.
58. Young HM. Embryological origin of interstitial cells of Cajal. Microsc Res Tech47:303-308, 1999
59.
59. Robinson TL, Sircar K, Hewlett BR, Chorneyko K, Riddel RH, Huizinga JD. Gastrointestinal stromal tumors may originate from a subset of CD34-positive interstitial cells of Cajal. Am J Pathol156:1157-1163, 2000
60.
60. Sirkar K, Hewlett BR, Huizinga JD, Chorneyko K, Berezin I, Riddel RH. Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors. Am J Surg Pathol23:377-389, 1999
61.
61. Schmid JS, Wegmann W.Gastrointestinal pacemaker cell tumor: Clinicopathological, immunohistochemical, and ultrastructural study with special reference to c-kit receptor antibody. Virchows Arch436:234-242, 2000
62.
62. Kindblom LG, Remotti HE, Aldenborg F, Meis-Kindblom JM. Gastrointestinal pacemaker cell tumor (GIPACT): Gastrointestinal stromal tumors show phenotypic characteristics of the intestitial cells of Cajal. Am J Pathol152:1259-1269, 1998
63.
63. Seidal T, Edvardsson H.Expression of c-kit (CD1 17) and Ki67 provides information about the possible cell origin and clinical course of gastrointestinal stromal tumours. Histopathology34:416-424, 1999
64.
64. Vanderwinden JM, Rumessen JJ, De Laet MH, Vanderhaeghen JJ, Schiffmann SN. CD34+ cells in human intestine are fibroblasts adjacent to but distinct from interstitial cells of Cajal. Lab Invest79:59-65, 1999
65.
65. Eyden B, Chorneyko KA, Shanks JH, Menasce LP, Banerjee SS. Contribution of electron microscopy to understanding cellular differentiation in mesenchymal tumors of the gastrointestinal tract: A study of 82 tumors. Ultrastruct Pathol26:269-285, 2002
66.
66. Yantiss RK, Rosenberg AE, Selig MK, Nielsen GP. Gastrointestinal stromal tumors: An ultrastructural study. Int J Surg Pathol10:101-103, 2002
67.
67. Wang L, Vargas H, French SW. Cellular origin of gastrointestinal stromal tumors: A study of 27 cases. Arch Pathol Lab Med124:1471-1475, 2002
68.
68. Lee JR, Joshi V, Griffin JW Jr, Lasota J, Miettinen M.Gastrointestinal autonomic nerve tumor: Immunohistochemical and molecular identity with gastrointestinal stromal tumor. Am J Surg Pathol25:979-987, 2002
69.
69. Lucas DR, Al-Abbadi M, Tabaczka P, Hamre MR, Weaver DW, Mott MJ. C-kit expression in desmoid fibromatosis. Comparative immunohistochemical evaluation of two commercial antinodies. Am J Clin Pathol119:339-345, 2003
70.
70. Hornick JL, Fletcher CDM. Validating immunohistochemical staining for KIT (CD1 17). Am J Clin Pathol119:325-327, 2003
71.
71. Yantiss RK, Spiro IJ, Compton CC, Rosenberg AE. Gastrointestinal stromal tumor versus intra-abdominal fibromatosis of the bowel wall: A clinically important differential diagnosis. Am J Surg Pathol24:947-957, 2000
72.
72. Montgomery E, Toberson MS, Kaushal M, Fisher C, Abraham SC. Beta-catenin immunohistochemistry separates mesenteric fibromatosis from gastrointestinal stromal tumor and sclerosing mesenteritis. Am J Surg Pathol26:1296-1301, 2002
73.
73. Shidham VB, Chivucula M, Gubta D, Rao N, Komorowski R.Immunohistochemical comparison of gastrointestinal stromal tumor and solitary fibrous tumor. Arch Pathol Lab Med126:1189-1192, 2002
74.
74. Plaat BEC, Hollema H, Molenaar WM, Broers GHT, Pijpe J, Mastik MF, Hoekstra HJ, van den Berg E, Scheper RJvan der Graaf WTA. Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: Differences in clinical outcome and expression of multidrug resistance proteins. J Clin Pathol18:3211-3220, 2000
75.
75. Sarlomo-Rikala M, El-Rifai W, Lahtinen T, Anderson LC, Miettinen M, Knuutila S.Different patterns of DNA copy number changes in gastrointestinal stromal tumors, leiomyomas, and schwannomas. Hum Pathol29:476-481, 1998
76.
76. Schaldenbrand JD, Appelman HD. Solitary solid stromal gastrointestinal tumors in von Recklinghausen's disease with minimal smooth muscle differentation. Hum Pathol15:229-232, 1994
77.
77. Carney JA. Gastric stromal sarcoma, pulmonary chondroma, and extra-adrenal paraganglioma (Carney trial): Natural history adrenocortical component, and possible familiar occurrence. Mayo Clin Proc74:543-552, 1999
78.
78. Carney JA, Stratakis CA. Familiar paraganglioma and gastric stromal sarcoma: A new syndrome distinct from the Carney trial. Am J Med Genet108:132-139, 2002
79.
79. O'Brien P, Kapusta L, Dardick I, Axler J, Gnidec A.Multiple familiar gastrointestinal autonomic nerve tumors and small intestinal neuronal dysplasia. Am J Surg Pathol23:198-204, 1999
80.
80. Nishida T, Hirota S, Taniguchi M, Hashimoto K, Isozaki K, Nakamura H, Kanakura Y, Tanaka T, Takabayashi A, Matsuda H, Kitamura Y.Familial gastrointestinal stromal tumours with germline mutation of the KIT gene. Nat Genet19:323-324, 1998
81.
81. Maiorana A, Fante R, Cesinaro A, Fano R.Synchronous occurrence of epithelial and stromal tumors in the stomach: A report of 6 cases. Arch Pathol Lab Med124:682-686, 2000
82.
82. Kerr JZ, Hicks MJ, Nuchtern JG, Saldivar V, HeimHall J, Shah S, Kelly DR, Cain WS, Chintagumpala MM. Gastrointestinal autonomic nerve tumors in the pediatric population. A report of four cases and a review of the literature. Cancer85:220-230, 1999
83.
83. Bates AW, Feakins FM, Scheimberg I.Congenital gastrointestinal stromal tumour is morphologically indistinguishable from the adult form, but does not express CD 117 and carries a favourable prognosis. Histopathology37:316-323, 2000
84.
84. Hamazoe R, Shimizu N, Nishidoi H, Maeta M, Koga S.Gastric leiomyoblastoma in chidhood. J Pediatr Surg26:225-227, 1991
85.
85. Persson S, Kindblom LG, Angervall L, Tisell LE. Metastasizing gastric epithelioid leiomyosarcomas (leiomyoblastomas) in young individuals with long-term survival. Cancer70:721-732, 1992
86.
86. Farrugia G, Kim CH, Grant CS, Zinsmeister AR. Leiomyosarcoma of the stomach. Determinants of long-term survival. Mayo Clin Proc67:533-536, 1992
87.
87. Palmer ED. Benign intramural tumors of the stomach. A review with special reference to gross pathology. Medicine (Baltimore)30:81-181, 1951
88.
88. Golden T, Stout AP. Smooth muscle tumors of the gastrointestinal tract and retroperitoneal tissues. Surg Gynecol Obstet73:784-810, 1941
89.
89. Ng EH, Pollock RE, Romsdahl MM. Prognostic implications of patterns of failure for gastrointestinal leiomyosarcomas. Cancer69:1334-1341, 1992
90.
90. Salmela H.Smooth muscle tumours of the stomach. A clinical study of 112 cases. Acta Chir Scand134:384-391, 1968
91.
91. Demetri GD, von Mehren M, Blanke CD, Van den Abbele A, Eisenberg B, Roberts PJ, Heinrich MC, Tuveson DA, Singer S, Janicek M, Fletcher JA, Sliverman SG, Silberman SL, Capdeville R, Kiese B, Peng B, Dimitrijeciv S, Druker BH, Corless C, Fletcher CDM, Joensuu H.Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med347:472-480, 2002
92.
92. De Matteo RP, Heinrich MC, El-Rifai WM, Demetri G.Clinical management of gastrointestinal stromal tumors: Before and after STI-571. Hum Pathol33:466-477, 2002
93.
93. Shiu MH, Farr GH, Papachristou DN, Hajdu SI. Myosarcomas of the stomach. Natural history, prognostic factors and management. Cancer49:177-187, 1982
94.
94. Appelman HD, Helwig EB. Sarcomas of the stomach. Am J Clin Pathol67:2-10, 1977
95.
95. Appelman H, Helwig EB. Cellular leiomyomas of the stomach in 49 patients. Arch Pathol Lab Med101:373-377,1977
96.
96. Evans HL. Smooth muscle tumors of the gastrointestinal tract. A study of 56 cases followed for a minimun of 10 years. Cancer56:2242-2250,,1985
97.
97. Trupiano JK, Stewart RE, Misick C, Appelman HD, Goldblum JR. Gastric stromal tumors: A clinicopathologic study of 77 cases with correlation of features with nonaggressive and aggressive clinical behaviours. Am J Surg Pathol26:705-714, 2002
98.
98. Ranchod M, Kempson RL. Smooth muscle tumors of the gastrointestinal tract and retroperitoneum. A pathologic analysis of 100 cases. Cancer39:255-262, 1977
99.
99. Tornoczky T, Kalman E, Hegedus G, Horvath OP, Sapi Z, Antal L, Jackso P, Pajor L.High mitotic index associated with poor prognosis in gastrointestinal autonomic nerve tumour. Histopathology35:121-128, 1999
100.
100. Hamin MB, Ma CK, Linden MD, Kubus JJ, Zarbo RJ. Prognostic value of proliferating cell nuclear antigen index in gastric stromal tumors. Correlation with mitotic count and clinical outcome. Am J Clin Pathol100:428-432, 1993
101.
101. Franquemont DW. Differentiation and risk assessment of gastrointestinal stromal tumors. Am J Clin Pathol103:41-47, 1995
103. Ray R, Tahan SR, Andrews C, Goldman H.Stromal tumors of the stomach. Prognostic value of the PCNA index. Mod Pathol7:26-30, 1994
104.
104. Hasegawa T, Matsuno Y, Shimoda JT, Hirohashi S.Gastrointestinal stromal tumor: Consistent CD 177 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade. Hum Pathol33:669-676, 2002
105.
105. Emory TS, Sobin LH, Lukes L, Lee DH, O'Leary TJ. Prognosis of gastrointestinal smooth-muscle (stromal) tumors: Dependence on anatomic site. Am J Surg Pathol23:82-87, 1999
107. Franquemont DW, Frierson HF Jr.Muscle differentiation and clinicopathologic features of gastrointestinal stromal tumors. Am J Surg Pathol16:947-954, 1992
108.
108. Cooper PN, Quirke P, Hardy GJ, Dixon MD. A flow cytometric, clinical and histological study of stromal neoplasms of the gastrointestinal tract. Am J Surg Pathol16:163-170, 1992
109.
109. El-Naggar AK, Ro JY, McLemore D, Garnsey L, Ordonez N, MacKay B.Gastrointestinal stromal tumors. DNA flow-cytometric study of 58 patients with at least five years of follow-up. Mod Pathol2:511-515, 1989
110.
110. Flint A, Appelman HD, Beckwith AL. DNA analysis of gastric stromal neoplasms: Correlation with pathologic features. Surg Pathol2:117-124, 1989
111.
111. Lerma E, Oliva E, Tugues D, Prat J.Stromal tumours of the gastrointestinal tract. A clinicopathological and ploidy analysis of 33 cases. Virchows Arch424:19-24, 1994
112.
112. Tsushima K, Rainwater LM, Goellner JE, van Heerden JA, Lieber MM. Leiomyosarcomas and benign smooth muscle tumors of the stomach. Nuclear DANN patterns studied by flow cytometry. Mayo Clin Proc62:275-280, 1987
113.
113. Carrillo R, Candia A, Rodriquez-Peralto JL, Caz V.Prognostic significance of DNA ploidy and proliferative index (MIB-1 index) in gastrointestinal stromal tumors. Hum Pathol28:160-164, 1997
114.
114. Rudolph P, Gloeckner K, Parwaresch R, Harms D, Schmidt D.Immunophenotype, proliferation, DNA ploidy, and biological behaviour. Virchows Arch441:238-248, 2002
115.
115. Cunningham JRE, Abbondanzo SL, Chu WS, Emory TS, Sobin KH, O'Leary TJ. Apoptosis, bcl-2 expression, and p53 expression in gastrointestinal stromal/smooth muscle tumors. Appl Immunohistochem Mol Morph9:19-23, 2001
116.
116. O'Leary TJ, Ernst S, Przygodzki R, Emory T, Sobin L.Loss of heterozygosity at lp63 predicts poor prognosis in gastrointestinal stroma/smooth muscle tumors. Lab Invest79:1461-1467, 1999
117.
117. Gunawan B, Bergmann F, Hoer J, Langer C, Schumpelick V, Becker H, Fuzesi L.Biological and clinical significance of cytogenetic abnormalities in low-risk and high-risk gastrointestinal stromal tumors. Hum Pathol33:316-321, 2002
118.
118. Sakurai S, Fukayama M, Kaizaki Y, Saito K, Kanazawa K, Kitamura M, Iwasaki Y, Hishima JT, Hayashi Y, Koike M.Telomerase activity in gastrointestinal stromal tumors. Cancer83:2060-2066, 1998
119.
119. Panizo-Santos A, Sola I, Vega F, de Alava E, Lozano MD, Iodate MA, Pardo-Mindan J.Predicting metastatic risk of gastrointestinal stromal tumors: Role of cell proliferation and cell cycle regulatory proteins. Int J Surg Pathol8:133-144, 2000
120.
120. Ernst SI, Hubbs AE, Przygodzki RM, Emory TS, Sobin LH, O'Leary TJ. KIT mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors. Lab Invest78:1633-1636, 1998
121.
121. Lasota J, Jasinski M, Sarlomo-Rikala M, Miettinen M.Mutations in Exon 11 of c-kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas. Am J Pathol154:53-60, 1999
